Lexeo Therapeutics, Inc. Common Stock

NASDAQ:LXEO

Biotechnology

Healthcare
$2.95 -0.94%

-$0.05 today

Market cap
$244.23M
Beta
1.39
P/E (TTM)
-4.6
EPS (TTM)
-$1.08
52W Low $3.60High $10.99

Volume 1.76M

Average 0.86M

Balance Sheet

Inspect the capital base behind the business.

Assets

$268.69M

FY 2025 · Annual

+82.9% YoY

Liabilities

$22.02M

FY 2025 · Annual

-26.8% YoY

Equity

$246.67M

FY 2025 · Annual

+111.1% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents135.86M77.34M121.47M35.01M63M
Short-term Investments00086.5M118.77M
Net Receivables00000
Inventory00000
Other Current Assets696K371K3K4.6M6.63M
Total Current Assets136.68M80.05M124.29M126.12M188.39M
Property, Plant & Equipment (Net)174K13.78M12.26M10.56M8.86M
Goodwill00000
Intangible Assets00000
Long-term Investments0007.01M68.19M
Tax Assets00000
Other Non-current Assets2K7.49M3.25M3.25M3.25M
Total Non-current Assets176K21.26M15.51M20.82M80.3M
Total Assets136.86M97.08M139.81M146.94M268.69M
Account Payables3.06M2.68M3.79M6.42M4.86M
Short-term Debt0002.67M0
Tax Payables528K506K157K00
Deferred Revenue46K0000
Other Current Liabilities961K2.15M3.36M4.66M4.14M
Total Current Liabilities7.45M14.35M17.24M22.85M16.81M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities185.01M185.03M000
Total Non-current Liabilities185.01M195.68M9.03M7.25M5.21M
Total Liabilities192.46M210.03M26.27M30.1M22.02M
Common Stock1.68K03K3K7K
Retained Earnings(56.17M)(115.45M)(181.84M)(280.17M)(380.13M)
Accumulated OCI(185.01M)(185.03M)0(103K)188K
Other Stockholders Equity863185.03M000
Minority Interest00000
Total Equity(55.6M)(112.95M)113.54M116.84M246.67M
Total Debt013.48M11.64M9.92M7.89M
Net Debt(135.86M)(63.85M)(109.83M)(25.09M)(55.11M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$71.8M
Other Current$129.1M
Total Current Assets$200.9M
PP&E (Net)$8.3M
Long-term Investments$34.5M
Other Non-current$6.6M
Total Non-current Assets$49.5M
Total Assets$250.4M

Analysis

Selected assets total $250.4M for Latest. The largest visible component is Other Current at $129.1M, about 51.6% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13G/ASC 13G/A filingNov 13, 2026
SC 13GSC 13G filingNov 10, 2026
EFFECTEFFECT filingNov 4, 2026
S-3S-3 filingOct 29, 2026
SC 13GSC 13G filingOct 13, 2026

How much cash does LXEO have?

Lexeo Therapeutics, Inc. Common Stock (LXEO) reported $63.00M in cash and equivalents in fiscal 2025.

How much debt does LXEO carry?

Lexeo Therapeutics, Inc. Common Stock (LXEO) reported $7.89M of total debt, with net debt of -$55.11M.